恒瑞医药(01276.HK)HRS-2430注射液获药物临床试验批准通知书

Core Viewpoint - Heng Rui Medicine has received approval from the National Medical Products Administration for the clinical trial of HRS-2430 injection, which will be conducted soon [1] Group 1: Drug Information - Drug Name: HRS-2430 Injection [1] - Dosage Form: Injection [1] - Application Matter: Clinical Trial [1] - Acceptance Numbers: CXHL2500810, CXHL2500811 [1] - Approval Conclusion: The clinical trial application for HRS-2430 injection, accepted on August 4, 2025, meets the requirements for drug registration and is approved for clinical trials in general anesthesia induction and maintenance, as well as sedation and anesthesia in non-tracheal intubation surgeries/procedures [1]